Dr. Jerry Mark Fletcher, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 W Hill Blvd, 628 Medical Group Pharmacy, Joint Base Charleston, SC 29404 Phone: 843-963-6809 |
Laura Mansfield Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 W Hill Blvd, Joint Base Charleston, SC 29404 Phone: 843-963-6880 |
Miki Christine Hinchey, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 204 W Hill Blvd, Joint Base Charleston, SC 29404 Phone: 843-963-6833 |
News Archive
Bristol-Myers Squibb has announced that Sustiva® (efavirenz) has received approval from the U.S. Food and Drug Administration to include new long-term virologic and clinical data from BMS Study 006 in its prescribing information.
SuperCom Ltd., a leading provider of secure solutions for the e-Government, Public Safety, HealthCare, and Finance sectors, today announced that it has been awarded new contracts, totaling approximately $8 million. The Company expects to deliver and recognize the full value of the orders during the first half of 2016.
New research from Georgetown University Medical Center suggests that the brain may not have developed a specific ability for "understanding faces" but instead uses the same kind of pattern recognition techniques to distinguish between people as it uses to search for differences between other groups of objects, such as plants, animals and cars.
Fluidigm today announced that its Singapore factory has manufactured and shipped more than 1 billion microscopic NanoFlex™ valves. Each NanoFlex valve is so small that it takes 10 to span the width of a human hair.
BioNumerik Pharmaceuticals, Inc. today announced the treatment of the first patients in a global multi-center Phase III clinical trial of Tavocept (BNP7787) in patients with primary adenocarcinoma of the lung, the most common type of lung cancer. In previous studies, Tavocept demonstrated the potential to substantially increase overall and one year patient survival while concurrently preventing and reducing the incidence and severity of common chemotherapy side-effects as compared to other currently available treatments for advanced lung cancer.
› Verified 4 days ago